-
-
[1]WeeginkCJ, SentjensRE , BeldMG , etal.ChronichepatitisCpatientswithapost-treatmentvirologicalrelapsere-treatedwithaninductiondoseof18MUinterferon-alphaincombinationwithribavirinandaman tadine:atwo-armrandomizedpilotstudy[J].JViralHepat, 2003, 10∶174-182. [2]Steindl-MundaP , FerenciP , BrnnerH , etal.Impactofhigh-doseinterferoninductionandribavirintherapyinpatientswithchronichepatitisCrelapsingafterornotrespondingtointerferonmonotherapy[J].LiverInt, 2003, 23∶269-275 [3]KotzevⅠ, IvanovaⅠ, AtanassovaM , etal.Highinitialdosecombina tionregimenwithinterferon-alphaandribavirininchronichepatitisC[J].Hepatogastroenterology, 2003, 50∶463-466. [4]P啨rez-OlmedaM , N挷 ezM , RomeroM , etal.PegylatedIFN -al pha2bplusribavirinastherapyforchronichepatitisCinHIV -infectedpatients[J].AIDS , 2003, 17∶1023-1028. [5]ButiM , MedinaM , CasadoMA , etal.Acost-effectivenessanalysisofpeginterferonalfa-2bplusribavirinforthetreatmentofnaivepatientswithchronichepatitis[J].AlimentPharmacolTher, 2003, 17∶687-694. [6]PockrosPJ, ReindollarR , McHutchinsonJ, etal.Thesafetyandtolera bilityofdailyinfergenplusribavirininthetreatmentofna姫 vechronichepatitisCpatients[J].JViralHepat, 2003, 10∶55-60. [7]FujiyamaS , ChikazawaH , HondaY , etal.EffectiveinterferontherapyforchronichepatitisCpatientswithlowviralloads[J].Hepatogas troenterology, 2003, 50∶817-820. [8]JessnerW , StauberR , HacklF , etal.Earlyviralkineticsontreatmentwithpegylatedinterferon-alpha-2ainchronichepatitisCvirusgeno type1infection[J].JViralHepat, 2003, 10∶37-42. [9]AraseY , IkedaK , TsubotaA , etal.EfficacyofprolongedinterferontherapyforpatientswithchronichepatitisCwithHCV -genotype1bandhighvirusload[J].JGastroenterol, 2003, 38∶158-163. [10]HoriikeN , HinoH , TanakaY , etal.Combinationtherapywithinter feronalphaandbetatochronichepatitisC[J].OncolRep, 2003, 10∶157-161. [11]FormannE , JessnerW , BennettL , etal.Twice-weeklyadministra tionofpeginterferon-alpha-2bimprovesviralkineticsinpatientswithchronichepatitisCgenotype1[J].JViralHepat, 2003, 10∶271-276. [12]InoueK , SekiyamaK , YamadaM , etal.Combinedinterferonalpha2bandcyclosporinAinthetreatmentofchronichepatitisC :controlledtrial[J].JGastroenterol, 2003, 38∶567-572. [13]CotlerSJ, MorrisseyMJ , WileyTE , etal.Apilotstudyofthecombi nationofcyclosporinAandinterferonalfacon-1forthetreatmentofhep atitisCinpreviousnonresponderpatients[J].JClinGastroenterol, 2003, 36∶352-355. [14]BizollonT , AhmedSN , RadenneS , etal.Longtermhistologicalim provementandclearanceofintrahepatichepatitisCvirusRNAfollowingsustainedreponsetointerferon-ribavirincombinationtherapyinlivertransplantedpatientswithhepatitisCvirusrecurrence[J].Gut, 2003, 52∶283-287. [15]HoofnagleJH , GhanyMG , KleinerDE , etal.MaintenancetherapywithribavirininpatientswithchronichepatitisCwhofailtorespondtocombinationtherapywithinterferonalfaandribavirin[J].Hepatology, 2003, 38∶66-74. [16]ThuluvathPJ , PandeH , MaygersJ.Combinationtherapywithinterferon-alpha (2b) , ribavirin, andamantadineinchronichepatitisCnonre sponderstointerferonandribavirin[J].DigDisSci, 2003, 48∶594-597. [17]YangSS , TuTC , WuCH , etal.Combinationofinterferonalfa-2aandamantadinedoesnotimprovetheefficacyofinterferontherapyinpa tientswithchronichepatitisC[J].Hepatogastroenterology, 2003, 50∶1575-1578.
本文二维码
计量
- 文章访问数: 3124
- HTML全文浏览量: 3
- PDF下载量: 838
- 被引次数: 0